Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis.

Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis.

To determine whether serum immunity to Porphyromonas gingivalis peptidylarginine deiminase (PPAD) affects the clinical response to biological disease-modifying antirheumatic drug (bDMARD) in patients with rheumatoid arthritis (RA).In a retrospective study, rheumatologic and periodontal conditions of...

Full description

Bibliographic Details
Main Authors: Tetsuo Kobayashi, Satoshi Ito, Daisuke Kobayashi, Atsushi Shimada, Ichiei Narita, Akira Murasawa, Kiyoshi Nakazono, Hiromasa Yoshie
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4844134?pdf=render

Internet

http://europepmc.org/articles/PMC4844134?pdf=render

Similar Items